{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:08:24Z","timestamp":1780096104121,"version":"3.54.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3375-5","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T14:23:13Z","timestamp":1496154193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Calretinin as a blood-based biomarker for mesothelioma"],"prefix":"10.1186","volume":"17","author":[{"given":"Georg","family":"Johnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Gawrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Raiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaantje","family":"Casjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur W.","family":"Musk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W. S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"3375_CR1","unstructured":"IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: asbestos. IARC Monogr Eval Carcinog Risk Chem Man. 1977;14:1\u2013106."},{"key":"3375_CR2","first-page":"11","volume":"100C","author":"IARC","year":"2012","unstructured":"IARC. Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum. 2012;100C:11\u2013465.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"5","key":"3375_CR3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10552-014-0368-4","volume":"25","author":"SJ Schonfeld","year":"2014","unstructured":"Schonfeld SJ, McCormack V, Rutherford MJ, Schuz J. Regional variations in German mesothelioma mortality rates: 2000-2010. Cancer Causes Control. 2014;25(5):615\u201324.","journal-title":"Cancer Causes Control"},{"key":"3375_CR4","unstructured":"AMR: Australian Mesothelioma Registry 3rd annual report: Mesothelioma in Australia 2013. Canberra: Safe Work Australia; 2014."},{"issue":"5","key":"3375_CR5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2013;137(5):647\u201367.","journal-title":"Arch Pathol Lab Med."},{"issue":"2","key":"3375_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/092986712803414204","volume":"19","author":"M Malerba","year":"2012","unstructured":"Malerba M, Montuschi P. Non-invasive biomarkers of lung inflammation in smoking subjects. Curr Med Chem. 2012;19(2):187\u201396.","journal-title":"Curr Med Chem"},{"issue":"6","key":"3375_CR7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","volume":"41","author":"V Panou","year":"2015","unstructured":"Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Roe OD. The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev. 2015;41(6):486\u201395.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3375_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13665-015-0106-8","volume":"4","author":"J Creaney","year":"2015","unstructured":"Creaney J, Dick IM, Robinson BW. Discovery of new biomarkers for malignant mesothelioma. Current pulmonology reports. 2015;4(1):15\u201321.","journal-title":"Current pulmonology reports"},{"key":"3375_CR9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-10-242","volume":"10","author":"I Raiko","year":"2010","unstructured":"Raiko I, Sander I, Weber DG, Raulf-Heimsoth M, Gillissen A, Kollmeier J, et al. Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. BMC Cancer. 2010;10:242.","journal-title":"BMC Cancer"},{"issue":"3","key":"3375_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1083\/jcb.105.3.1343","volume":"105","author":"JH Rogers","year":"1987","unstructured":"Rogers JH. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol. 1987;105(3):1343\u201353.","journal-title":"J Cell Biol"},{"issue":"9","key":"3375_CR11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","volume":"20","author":"C Doglioni","year":"1996","unstructured":"Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20(9):1037\u201346.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3375_CR12","first-page":"4003","volume":"24","author":"B Schwaller","year":"2004","unstructured":"Schwaller B, Celio MR, Doglioni C. Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases. Anticancer Res. 2004;24(6):4003\u20139.","journal-title":"Anticancer Res"},{"key":"3375_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12931-015-0311-6","volume":"16","author":"W Blum","year":"2015","unstructured":"Blum W, Pecze L, Felley-Bosco E, Schwaller B. Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration. Respir Res. 2015;16:153.","journal-title":"Respir Res"},{"issue":"8","key":"3375_CR14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.5858\/arpa.2013-0381-RA","volume":"139","author":"Q Arif","year":"2015","unstructured":"Arif Q, Husain AN. Malignant Mesothelioma Diagnosis. Arch Pathol Lab Med. 2015;139(8):978\u201380.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3375_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2006.08.010","volume":"38","author":"NG Ordonez","year":"2007","unstructured":"Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol. 2007;38(1):1\u201316.","journal-title":"Hum Pathol"},{"issue":"3","key":"3375_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","volume":"50","author":"K Chang","year":"1992","unstructured":"Chang K, Pastan I, Willingham MC. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. Int J Cancer. 1992;50(3):373\u201381.","journal-title":"Int J Cancer"},{"issue":"9396","key":"3375_CR17","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003;362(9396):1612\u20136.","journal-title":"Lancet"},{"issue":"4","key":"3375_CR18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","volume":"53","author":"HL Beyer","year":"2007","unstructured":"Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, et al. MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem. 2007;53(4):666\u201372.","journal-title":"Clin Chem"},{"issue":"9","key":"3375_CR19","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1055-9965.EPI-10-0346","volume":"19","author":"J Creaney","year":"2010","unstructured":"Creaney J, Olsen NJ, Brims F, Dick IM, Musk AW, de Klerk NH, et al. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Cancer Epidemiol Biomark Prev. 2010;19(9):2238\u201346.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"3375_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00204-010-0580-2","volume":"85","author":"M Gube","year":"2011","unstructured":"Gube M, Taeger D, Weber DG, Pesch B, Brand P, Johnen G, et al. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. Arch Toxicol. 2011;85(3):185\u201392.","journal-title":"Arch Toxicol"},{"issue":"5","key":"3375_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/JTO.0b013e31820db377","volume":"6","author":"K Hollevoet","year":"2011","unstructured":"Hollevoet K, Van Cleemput J, Thimpont J, De Vuyst P, Bosquee L, Nackaerts K, et al. Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. J Thorac Oncol. 2011;6(5):889\u201395.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3375_CR22","volume":"9","author":"DG Weber","year":"2014","unstructured":"Weber DG, Casjens S, Johnen G, Bryk O, Raiko I, Pesch B, et al. Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis. PLoS One. 2014;9(12):e114483.","journal-title":"PLoS One"},{"issue":"6","key":"3375_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/CBM-2007-3602","volume":"3","author":"DG Weber","year":"2007","unstructured":"Weber DG, Taeger D, Pesch B, Kraus T, Br\u00fcning T, Johnen G. Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma. Cancer Biomark. 2007;3(6):287\u201392.","journal-title":"Cancer Biomark"},{"issue":"3","key":"3375_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwk011","volume":"165","author":"NJ Perkins","year":"2007","unstructured":"Perkins NJ, Schisterman EF, Vexler A. Receiver operating characteristic curve inference from a sample with a limit of detection. Am J Epidemiol. 2007;165(3):325\u201333.","journal-title":"Am J Epidemiol"},{"key":"3375_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J. Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society Series A. 1972;135:185\u2013207.","journal-title":"Journal of the Royal Statistical Society Series A"},{"issue":"1","key":"3375_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/biomet\/65.1.167","volume":"65","author":"RL Prentice","year":"1978","unstructured":"Prentice RL. Linear rank tests with right censored data. Biometrika. 1978;65(1):167\u201379.","journal-title":"Biometrika"},{"key":"3375_CR27","volume-title":"Nondetects and data analysis: statistics for censored environmental data","author":"DR Helsel","year":"2005","unstructured":"Helsel DR. Nondetects and data analysis: statistics for censored environmental data. New York: Wiley & Sons; 2005."},{"key":"3375_CR28","first-page":"490","volume":"306","author":"T Isobe","year":"1986","unstructured":"Isobe T, Feigelson ED, Nelson PI. Statistical methods for astronomical data with upper limits. II Correlation and regression ApJ. 1986;306:490\u2013507.","journal-title":"II Correlation and regression ApJ"},{"issue":"6","key":"3375_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004200100240","volume":"74","author":"V Neumann","year":"2001","unstructured":"Neumann V, G\u00fcnther S, M\u00fcller KM, Fischer M. Malignant mesothelioma--German mesothelioma register 1987-1999. Int Arch Occup Environ Health. 2001;74(6):383\u201395.","journal-title":"Int Arch Occup Environ Health"},{"issue":"5","key":"3375_CR30","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbapap.2013.12.007","volume":"1844","author":"B Pesch","year":"2014","unstructured":"Pesch B, Br\u00fcning T, Johnen G, Casjens S, Bonberg N, Taeger D, et al. Biomarker research with prospective study designs for the early detection of cancer. Biochim Biophys Acta. 2014;1844(5):874\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"3375_CR31","doi-asserted-by":"crossref","first-page":"681416","DOI":"10.1155\/2015\/681416","volume":"2015","author":"O Blyuss","year":"2015","unstructured":"Blyuss O, Gentry-Maharaj A, Fourkala EO, Ryan A, Zaikin A, Menon U, et al. Serial patterns of ovarian cancer biomarkers in a Prediagnosis longitudinal dataset. Biomed Res Int. 2015;2015:681416.","journal-title":"Biomed Res Int"},{"issue":"3","key":"3375_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","volume":"82","author":"J Creaney","year":"2013","unstructured":"Creaney J, Dick IM, Segal A, Musk AW, Robinson BW. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer. 2013;82(3):491\u20138.","journal-title":"Lung Cancer"},{"issue":"3","key":"3375_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.lungcan.2015.09.021","volume":"90","author":"L Santarelli","year":"2015","unstructured":"Santarelli L, Staffolani S, Strafella E, Nocchi L, Manzella N, Grossi P, et al. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. Lung Cancer. 2015;90(3):457\u201364.","journal-title":"Lung Cancer"},{"key":"3375_CR34","volume-title":"Orecchia S, et al","author":"I Bononi","year":"2016","unstructured":"Bononi I, Comar M, Puozzo A, Stendardo M, Boschetto P. Orecchia S, et al. Oncotarget: Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers; 2016."},{"issue":"12","key":"3375_CR35","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-15-1130","volume":"22","author":"A Napolitano","year":"2016","unstructured":"Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, et al. HMGB1 and its Hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients. Clin Cancer Res. 2016;22(12):3087\u201396.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3375_CR36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2011.3978","volume":"15","author":"R Maeda","year":"2011","unstructured":"Maeda R, Tabata C, Tabata R, Eguchi R, Fujimori Y, Nakano T. Is serum thioredoxin-1 a useful clinical marker for malignant pleural mesothelioma? Antioxid Redox Signal. 2011;15(3):685\u20139.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"3375_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00408-016-9868-1","volume":"194","author":"M Demir","year":"2016","unstructured":"Demir M, Kaya H, Taylan M, Ekinci A, Yilmaz S, Teke F, et al. Evaluation of new biomarkers in the prediction of malignant mesothelioma in subjects with environmental asbestos exposure. Lung. 2016;194(3):409\u201317.","journal-title":"Lung"},{"key":"3375_CR38","volume-title":"Muley T","author":"MA Schneider","year":"2016","unstructured":"Schneider MA. Muley T. Warth A, Thomas M, Herth FJ, et al. Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma. Oncotarget: Kahn NC; 2016."},{"key":"3375_CR39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12014-016-9103-3","volume":"13","author":"DJ Morre","year":"2016","unstructured":"Morre DJ, Hostetler B, Taggart DJ, Morre DM, Musk AW, Robinson BW, et al. ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms. Clin Proteomics. 2016;13:2.","journal-title":"Clin Proteomics"},{"issue":"6","key":"3375_CR40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1515\/CCLM.2010.165","volume":"48","author":"EK Park","year":"2010","unstructured":"Park EK, Thomas PS, Creaney J, Johnson AR, Robinson BW, Yates DH. Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population. Clin Chem Lab Med. 2010;48(6):869\u201374.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"3375_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5301\/JBM.2011.8332","volume":"26","author":"A Cristaudo","year":"2011","unstructured":"Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, et al. Two novel polymorphisms in 5\u2032 flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. Int J Biol Markers. 2011;26(2):117\u201323.","journal-title":"Int J Biol Markers"},{"issue":"11","key":"3375_CR42","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/JTO.0000000000000322","volume":"9","author":"S Garritano","year":"2014","unstructured":"Garritano S, De Santi C, Silvestri R, Melaiu O, Cipollini M, Barone E, et al. A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people. J Thorac Oncol. 2014;9(11):1662\u20138.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3375_CR43","first-page":"1239","volume":"10","author":"S Garte","year":"2001","unstructured":"Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev. 2001;10(12):1239\u201348.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"20","key":"3375_CR44","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst. 2008;100(20):1432\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3375_CR45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1556-0864(15)31535-5","volume":"1","author":"J Creaney","year":"2006","unstructured":"Creaney J, Christansen H, Lake R, Musk AB, de Klerk N, Robinson BW. Soluble mesothelin related protein in mesothelioma. J Thorac Oncol. 2006;1(2):172\u20134.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"3375_CR46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2014.06.014","volume":"66","author":"T Behrens","year":"2014","unstructured":"Behrens T, Stenzl A, Br\u00fcning T. Factors influencing false-positive results for nuclear matrix protein 22. Eur Urol. 2014;66(5):970\u20132.","journal-title":"Eur Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3375-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:23:06Z","timestamp":1692822186000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3375-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3375-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"article-number":"386"}}